New Delhi: Phase II/III clinical trials of Covaxin, indigenous COVID-19 vaccine, in the 2-18-year-olds will begin in the next 10-12 days, senior NITI Aayog member VK Paul announced on Tuesday.
“COVAXIN has been approved by the Drugs Controller General of India (DCGI), for Phase II/III clinical trials in the age group of 2 to 18 years. I have been told that trials will begin in the next 10-12 days,” said Dr VK Paul, Member-Health, NITI Aayog.
The trial will take place in 525 subjects at various sites, NDTV reported.
Mumbai: Bhavesh Bhinde, who owns Ego Media Pvt. Ltd, the ad agency which installed the killer…
Bhubaneswar: In the wake of election violence in Khallikote which claimed one life, the poll…
New Delhi: Swati Maliwal has finally broken her silence three days after Arvind Kejriwal’s PA allegedly…
Bhubaneswar: As many as 18 (28%) of the 64 candidates in fray in the six…
New Delhi: Weeks after AstraZeneca admitted that its COVID vaccine, including Covishield, can cause rare side-effects…
Bhubaneswar: Former Odisha MLA Rajendra Kumar Das joined Biju Janata Dal (BJD) along with his…
Bhubaneswar: Odisha girl Aahan has been selected to join International Tennis Federation’s (ITF) Junior Grand…
Bhubaneswar: Amid high-voltage electioneering in Odisha, Biju Janata Dal (BJD) president and Chief Minister Naveen…